Company: SRPT
Filing Date: 2025-02-28
Form Type: 10-K
Source: 0000950170-25-029973
Chunk: 28

Company: Sarepta Therapeutics, Inc.
Filing Date: 2025-02-28
Form: 10-K
Item: Item 1B
Chunk 28
---
The following exhibits are filed herewith or are incorporated by reference to exhibits filed with the SEC:

    Incorporated by Reference to Filings Indicated

    ExhibitNumber
     
    Description
     
    Form
     
    File No.
     
    Exhibit
     
    FilingDate
     
    ProvidedHerewith

      2.1
     
    Agreement and Plan of Merger dated June 6, 2013 between Sarepta Therapeutics, Inc., a Delaware corporation, and Sarepta Therapeutics, Inc., an Oregon corporation.
     
    8-K12B
     
    001-14895
     
    2.1
     
    6/6/13

      2.2*
     
    Warrant to Purchase Common Stock of Myonexus Therapeutics, Inc., issued by Myonexus Therapeutics, Inc. to Sarepta Therapeutics, Inc., dated as of May 3, 2018.
     
    10-Q
     
    001-14895
     
    2.1
     
    8/8/18

      3.1
     
    Amended and Restated Certificate of Incorporation.
     
    8-K12B
     
    001-14895
     
    3.1
     
    6/6/13

      3.2
     
    Amendment to the Amended and Restated Certificate of Incorporation.
     
    8-K
     
    001-14895
     
    3.1
     
    6/30/15

      3.3
     
    Second Amended and Restated ByLaws of Sarepta Therapeutics, Inc.
     
    8-K
     
    001-14895
     
    3.1
     
    12/13/22

      3.4
     
    Amendment No. 1 to Second Amended and Restated Bylaws of Sarepta Therapeutics, Inc.
     
    8-K
     
    001-14895
     
    3.1
     
    9/16/24

      4.1
     
    Form of Specimen Certificate for Common Stock.
     
    10-Q